Read key findings from the 2022 National Survey on Drug Use and Health (NSDUH). This report highlights 2022 statistics on substance use, mental health, and treatment in the United States. These national indicators are measured...
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors interviewed...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
People with mental illness and/or SUD are disproportionally affected by HIV. They may participate in behaviours that increase risk for contracting and transmitting HIV, such as sharing injection drug equipment or...
Importance Substance use disorders are associated with high rates of emergency department (ED) use and challenges engaging with primary care services.
Objective To examine 5-year health care engagement and utilization outcomes...
NADCP is partnering with the American Society of Addiction Medicine (ASAM) to offer a new training for medical providers working with participants in drug treatment courts. This training will help medical providers learn how to successfully...
Psychologists are playing pivotal roles in reentry programs, but more research and investment are needed to help incarcerated individuals build successful lives after leaving prison.
This article, published in the American Psychological...
About the Report
Addiction Policy Forum’s (APF) Patient Experiences Journey Map was developed through the input of patients in treatment and recovery from substance use disorder (SUD). The map underscores the obstacles and positive points...
Abstract
Background
The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied.
Methods
We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a...
Importance Rates of prenatal cannabis use are increasing alongside perceptions that cannabis is a harmless therapeutic for pregnancy-related ailments, while rates of prenatal use of alcohol and tobacco are decreasing. It is...
Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for...
Importance Significant disparities exist in smoking behaviors by sexual minority status in the US.
Objective To examine potential differences in the associations between exposure to the Tips From Former Smokers (Tips) campaign...
Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and...
In response to the concerning numbers of opioid-related deaths in the US, there has been a recent focus on opioid prescribing trends, which has shown an increase in opioid tapering among patients prescribed long-term opioid therapy. However...
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities. With the immediate need for remote care due to the...
Background: Opioid use disorder (OUD) disproportionately impacts rural and American Indian communities and has quadrupled among pregnant individuals nationwide in the past two decades. Yet, limited data are available about access...
